Jury Vindicates Pfizer In First Zoloft Birth Defect Trial
Pfizer Inc. notched a victory Friday in the first trial over the alleged birth defect risks of its blockbuster antidepressant drug Zoloft, when a state jury in St. Louis shot down...To view the full article, register now.
Already a subscriber? Click here to view full article